Selected Publications

Khawaja F, Elgarten CW: Intravenous Brincidofovir Effectively Reduces CMV Dnaemia In Antiviral Experienced Immunocompromised Patients: Results of a Phase 2a Clinical Trial     Tandem Feb 2026.

Salomon AL, Ammann RA, Aftandilian C, Bochennek K, Brack E, Dupuis L, Elgarten CW, Esbenshade A, Haeusler GM, Karamatsu M, Moenster MB, Phillips B, Schaeffer E, Sung L, Tragiannidis A, Vissing NH, Koenig C: Association of Time to Antibiotics With Outcome in Pediatric Patients Receiving Chemotherapy for Cancer With Fever in Neutropenia—An International Individual Patient Data Meta-Analysis. Cancer Medicine 15(1): e71512, January 2026 Notes: https://doi.org/10.1002/cam4.71512.

Boulter A, Khuong QL, Tam V, Zheng D, Jung W, Huang Y S, Aftandilian C, Bona K, Elgarten C, Ghosh T, Gramatges M M, Maloney K, Mian A, Miller T, Mody R, Myers R, Seif A, Smith C, Stokke J, Vasanna S, Winick N, Wilkes J, Wong V, Fisher B, Li Y, Aplenc R, Getz K: Influence of air quality on clinical acuity at presentation in pediatric patients with newly diagnosed Acute Myeloid Leukemia. ASH Dec 2025.

Elgarten C, Alonzo T, Gerbing R, Choi J, Fisher B, Hirsch B, Kahwash S, Levine J, Brodersen L, Loken M, Raimondi S, Tarlock K, Wood A, Sung L, Cooper T, Gamis A, Meshinchi S, Aplenc R, Pollard J: Post-transplant maintenance with sorafenib is safe and effective in pediatric patients with har FLT3/ITD AML: A report from the Children’s oncology group protocol AAML1031. ASH Dec 2025.

Myers R, Li Y, Liu H, Hoover A, Shinehouse L, Hinson A, Kohorst M, Elias A, Keenan E, Acres H, Ahmed I, Al-Mulla A, Arthur L, Beck J, Berry A, Bhatla D, Briscoe E, Chang G, Chu R, Davis L, Dolan J G, Elo L, Eom E, Escobar Vasco A, Fabrizio V, Faulk K, Galan-Gomez V, Goode E, Grupp S, Hall A, Hamill D, Vasanna S, Kinoshita H, Krieger E, Lee-Miller C, Lind K, Milner J, Moore-Higgs G, Moskop A, Murphy L, Murphy M, Nguyen G, Ortega M, Patel H, Perez A, Pfeiffer T, Prosser-Dombrowski A, Rahim M, Rahrig A, Ramachandran S, Hammoud M S, Saraf A, Shoag J, Symons H, Tastet N, Thomas S, Thornock M, Toner K, Weisnicht A, Zarnegar-Lumley S, Shah N, Maude S, Rubinstein J, Quigg T, Bhojwani D, Elgarten C: Optimal therapy for pediatric B-ALL in first relapse: Comparative effectiveness of blinatumomab to hematopoietic cell transplantation versus CD19 CAR T cell therapy American Society of Hematology Dec 2025.

Zheng D, Khuong Q L, Aftandilian C, Bona K, Boulter A, Caywood E, Elgarten C, Gathers C, Ghosh T, Gramatges M M, Henry M, Hettinger G, Huang Y S, Li Y, Maloney K, Mian A, Miller T, Mody R, Myers R, Ortiz J, Seif A, Smith C, Stokke J, Vasanna S, Winick N, Wilkes J, Wong V, Fisher B, Aplenc R, Getz K: Real-world post-relapse survival outcomes in children with Acute Myeloid Leukemia by race and ethnicity. ASH Dec 2025.

Lind K, Berry A, Li Y, Liu H, Rubinstein J, Nguyen G, Fabrizio V, Hall A, Bhojwani D, Quigg T, Maude S, Shah N, Ortega M, Al-Mulla A, Ahmed I, Beck J, Bhatla D, Briscoe E, Chu R, Davis L, Dolan J G, Drinkwine J, Elias A, Elo L, Eom E, Faulk K, Goode E, Hamill D, Hammoud M S, Hinson A, Hoover A, Kinoshita H, Kohorst M, Krieger E, Lee-Miller C, McNerney K, Milner J, Moskop A, Moore-Higgs G, Murphy L, Murphy M, Patel H, Pfeiffer T, Prosser-Dombrowski A, Rahim M, Rahrig A, Saraf A, Shoag J, Symons H, Tastet N, Thomas S, Thornock M, Toner K, Vasanna S, Escobar Vasco A, Weisnicht A, Zarnegar-Lumley S, Winestone L, Myers R, Elgarten C: Survival after first relapse of pediatric B-ALL differs by insurance type: A real-world analysis from the recall-1 study. American Society of Hematology Dec 2025.

Elgarten C, Li Y, Xie Y, Wang L, Aftandilian C, Bona K, Ghosh T, Gramatges M M, Maloney K, Martin A, Miller T, Mody R, Smith C, Stokke J, Vasanna S, Wilkes J, Wong V, Myers R, Getz K, Aplenc R: Optimization of induction chemotherapy in pediatric patients with Acute Myeloid Leukemia: Real-world evidence to support removal of etoposide from induction 1. ASH? Dec 2025.

Berry A, Elgarten C, Li Y, Liu H, Lind K, Zheng D, Nguyen G, Fabrizio V, Ortega M, Rubinstein J, Quigg T, Hall A, Bhojwani D, Shah N, Maude S, Zarnegar-Lumley S, Weisnicht A, Toner K, Thornock M, Thomas S, Tastet N, Symons H, Shoag J, Saraf A, Rahrig A, Rahim M, Prosser-Dombrowski A, Pfeiffer T, Patel H, Murphy M, Murphy L, Moskop A, Moore-Higgs G, Milner J, McNerney K, Lee-Miller C, Kohorst M, Kinoshita H, Krieger E, Vasanna S, Hoover A, Hinson A, Hammoud M S, Hamill D, Goode E, Faulk K, Escobar Vasco A, Elo L, Elias A, Eom E, Drinkwine J, Dolan J G, Davis L, Chu R, Briscoe E: Disparate post-relapse survival outcomes by race/ethnicity for children with B-cell acute lymphoblastic leukemia: An analysis from the recall-1 stud. ASH Dec 2025.

Khuong QL, Zheng D, Hettinger G, Elgarten C, Boulter A, Aftandilian C, Bona K, Ghosh T, Gramatges M M, Huang Y S, Maloney K, Mian A, Miller T, Vasanna S, Mody R, Myers R, Seif A, Smith C, Stokke J, Winick N, Wilkes J, Wong V, Fisher B, Ky B, Li Y, Aplenc R, Getz K: Early cardiotoxicity and survival in pediatric Acute Myeloid Leukemia: The mediating roles of relapse and salvage chemotherapy intensity. ASH Dec 2025.